Literature DB >> 12228790

Determinants of tissue Doppler measures of regional diastolic function during dobutamine stress echocardiography.

Ofelia Najos-Valencia1, Peter Cain, Colin Case, Sudhir Wahi, Thomas H Marwick.   

Abstract

BACKGROUND: Diastolic dysfunction induced by ischemia may alter transmitral blood flow, but this reflects global ventricular function, and pseudonormalization may occur with increased preload. Tissue Doppler may assess regional diastolic function and is relatively load-independent, but limited data exist regarding its application to stress testing. We sought to examine the stress response of regional diastolic parameters to dobutamine echocardiography (DbE).
METHODS: Sixty-three patients underwent study with DbE: 20 with low probability of coronary artery disease (CAD) and 43 with CAD who underwent angiography. A standard DbE protocol was used, and segments were categorized as ischemic, scar, or normal. Color tissue Doppler was acquired at baseline and peak stress, and waveforms in the basal and mid segments were used to measure early filling (Em), late filling (Am), and E deceleration time. Significant CAD was defined by stenoses >50% vessel diameter.
RESULTS: Diastolic parameters had limited feasibility because of merging of Em and Am waves at high heart rates and limited reproducibility. Nonetheless, compared with normal segments, segments subtended with significant stenoses showed a lower Em velocity at rest (6.2 +/- 2.6 cm/s vs 4.8 +/- 2.2 cm/s, P <.0001) and peak (7.5 +/- 4.2 cm/s vs 5.1 +/- 3.6 cm/s, P <.0001). Abnormal segments also showed a shorter E deceleration time (51 +/- 27 ms vs 41 +/- 27 ms, P =.0001) at base and peak. No changes were documented in Am. The same pattern was seen with segments identified as ischemic with wall motion score. However, in the absence of ischemia, segments of patients with left ventricular hypertrophy showed a lower Em velocity, with blunted Em responses to stress.
CONCLUSION: Regional diastolic function is sensitive to ischemia. However, a number of practical limitations limit the applicability of diastolic parameters for the quantification of stress echocardiography.

Entities:  

Mesh:

Year:  2002        PMID: 12228790     DOI: 10.1067/mhj.2002.123836

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Usefulness of left ventricular diastolic function assessed by magnetic resonance imaging over invasive coronary flow reserve measurement for detecting cardiac allograft vasculopathy in heart transplant recipients.

Authors:  Haruhiko Machida; Shinichi Nunoda; Kazunobu Shitakura; Kiyotaka Okajima; Yutaka Kubo; Masami Hirata; Shinya Kojima; Eiko Ueno; Kuniaki Otsuka
Journal:  Int J Cardiovasc Imaging       Date:  2012-10-18       Impact factor: 2.357

2.  Magnetic resonance assessment of left ventricular diastolic dysfunction for detecting cardiac allograft vasculopathy in recipients of heart transplants.

Authors:  Haruhiko Machida; Shinichi Nunoda; Kiyotaka Okajima; Kazunobu Shitakura; Akihiko Sekikawa; Yutaka Kubo; Kuniaki Otsuka; Masami Hirata; Shinya Kojima; Eiko Ueno
Journal:  Int J Cardiovasc Imaging       Date:  2011-03-26       Impact factor: 2.357

3.  Strain rate imaging after dynamic stress provides objective evidence of persistent regional myocardial dysfunction in ischaemic myocardium: regional stunning identified?

Authors:  R I Williams; N Payne; T Phillips; J D'hooge; A G Fraser
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

4.  Tissue Doppler imaging estimation of pulmonary artery occlusion pressure in ICU patients.

Authors:  Alain Combes; Florence Arnoult; Jean-Louis Trouillet
Journal:  Intensive Care Med       Date:  2003-11-21       Impact factor: 17.440

5.  Speckle-tracking and tissue-Doppler stress echocardiography in arterial hypertension: a sensitive tool for detection of subclinical LV impairment.

Authors:  Kai O Hensel; Andreas Jenke; Roman Leischik
Journal:  Biomed Res Int       Date:  2014-10-15       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.